Form 1-A - Offering Statement [Regulation A]:
SEC Accession No. 0001104659-25-034238
Filing Date
2025-04-11
Accepted
2025-04-11 16:28:53
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A  
1 primary_doc.xml 1-A 16731
2 PART II AND III tm2511906-1_partiiandiii.htm PART II AND III 412542
3 EXHIBIT 3.25 tm2511906d2_ex3-25.htm EX1A-3 HLDRS RTS 108435
4 EXHIBIT 4.1 tm2511906d2_ex4-1.htm EX1A-4 SUBS AGMT 205708
5 EXHIBIT 11.1 tm2511906d2_ex11-1.htm EX1A-11 CONSENT 2501
6 GRAPHIC lg_biopathholdings-4clr.jpg GRAPHIC 15688
  Complete submission text file 0001104659-25-034238.txt   769011
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS, INC. (Filer) CIK: 0001133818 (see all company filings)

EIN.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A | Act: 33 | File No.: 024-12601 | Film No.: 25832433
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)